Name: UMIN ID:
Unique ID issued by UMIN | UMIN000010027 |
---|---|
Receipt number | R000011740 |
Scientific Title | Phase I/II clinical study of WT4869 peptide-based immunotherapy in patients with completely resected stage IA with vascular invasion, stage IB and stage II non-small cell lung cancer with WT1 antigen positive. |
Date of disclosure of the study information | 2013/02/13 |
Last modified on | 2015/07/13 19:56:52 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/02/13 18:09:08 | ||
2 | Update | 2013/02/15 14:23:10 | Recruitment status |
|
3 | Update | 2013/08/22 17:53:48 | Key inclusion criteria Key inclusion criteria Key exclusion criteria |
|
4 | Update | 2013/08/22 18:15:23 | TEL |
|
5 | Update | 2013/08/22 18:24:38 | Key exclusion criteria |
|
6 | Update | 2013/08/22 18:45:17 | Key inclusion criteria |
|
7 | Update | 2014/03/13 10:15:56 | Key inclusion criteria |
|
8 | Update | 2014/08/14 11:32:30 | Recruitment status |
|
9 | Update | 2015/03/13 09:22:04 | Organization Organization Category of Funding Organization |
|
10 | Update | 2015/07/13 19:56:53 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete |